{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T10:20:27Z","timestamp":1792059627994,"version":"4.4.0"},"reference-count":129,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,23]],"date-time":"2023-10-23T00:00:00Z","timestamp":1698019200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,10,23]],"date-time":"2023-10-23T00:00:00Z","timestamp":1698019200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["GeroScience"],"DOI":"10.1007\/s11357-023-00982-4","type":"journal-article","created":{"date-parts":[[2023,10,23]],"date-time":"2023-10-23T13:01:52Z","timestamp":1698066112000},"page":"621-643","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Neuropathological and sociodemographic factors associated with the cortical amyloid load in aging and Alzheimer\u2019s disease"],"prefix":"10.1007","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7865-1677","authenticated-orcid":false,"given":"Sayonara P.","family":"da Silva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7369-7660","authenticated-orcid":false,"given":"Carla C. M.","family":"de Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00edvia N.","family":"Rabelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5232-5275","authenticated-orcid":false,"given":"Rovena C.","family":"Engelberth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8080-5578","authenticated-orcid":false,"given":"Bernardino","family":"Fern\u00e1ndez-Calvo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2146-9989","authenticated-orcid":false,"given":"Felipe P.","family":"Fiuza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,23]]},"reference":[{"key":"982_CR1","doi-asserted-by":"publisher","unstructured":"Collaborators G 2019. Global mortality from dementia: application of a new method and results from the Global Burden Of Disease Study 2019. Alzheimer\u2019s Dement: Transl Res Clin Interv 2021. https:\/\/doi.org\/10.1002\/trc2.12200.","DOI":"10.1002\/trc2.12200"},{"key":"982_CR2","doi-asserted-by":"publisher","unstructured":"GBD 2019 Dementia Forecasting Collaborators. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019. Lancet Public Health. 2022. https:\/\/doi.org\/10.1016\/S2468-2667(21)00249-8.","DOI":"10.1016\/S2468-2667(21)00249-8"},{"key":"982_CR3","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"2013","unstructured":"American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Washington: American Psychiatric Publishing, Inc.; 2013.","edition":"5"},{"key":"982_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2020.101210","author":"P Mecocci","year":"2020","unstructured":"Mecocci P, Boccardi V. The impact of aging in dementia: it is time to refocus attention on the main risk factor of dementia. Ageing Res Rev. 2020. https:\/\/doi.org\/10.1016\/j.arr.2020.101210.","journal-title":"Ageing Res Rev"},{"key":"982_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-022-00523-1","author":"TE Golde","year":"2022","unstructured":"Golde TE. Alzheimer\u2019s disease \u2013 the journey of a healthy brain into organ failure. Mol Neurodegener. 2022. https:\/\/doi.org\/10.1186\/s13024-022-00523-1.","journal-title":"Mol Neurodegener"},{"key":"982_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2023.104511","author":"SJ Andrews","year":"2023","unstructured":"Andrews SJ, Renton AE, Fulton-Howard B, et al. The complex genetic architecture of Alzheimer\u2019s disease: novel insights and future directions. EBioMedicine. 2023. https:\/\/doi.org\/10.1016\/j.ebiom.2023.104511.","journal-title":"EBioMedicine"},{"key":"982_CR7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002270","author":"H-M Lanoisel\u00e9e","year":"2017","unstructured":"Lanoisel\u00e9e H-M, Nicolas G, Wallon D, et al. APP, PSEN1, and PSEN2 mutations in early-onset Alzheimer disease: a genetic screening study of familial and sporadic cases. PLoS Med. 2017. https:\/\/doi.org\/10.1371\/journal.pmed.1002270.","journal-title":"PLoS Med"},{"key":"982_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-021-00921-z","author":"DP Wightman","year":"2021","unstructured":"Wightman DP, Jansen IE, Savage JE, et al. A genome-wide association study with 1,126,563 individuals identifies new risk loci for Alzheimer\u2019s disease. Nat Genet. 2021. https:\/\/doi.org\/10.1038\/s41588-021-00921-z.","journal-title":"Nat Genet"},{"key":"982_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-022-01024-z","author":"C Bellenguez","year":"2022","unstructured":"Bellenguez C, K\u00fc\u00e7\u00fckali F, Jansen IE, et al. New insights into the genetic etiology of Alzheimer\u2019s disease and related dementias. Nat Genet. 2022. https:\/\/doi.org\/10.1038\/s41588-022-01024-z.","journal-title":"Nat Genet"},{"key":"982_CR10","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/7361613","volume-title":"Overview of Alzheimer's disease and some therapeutic approaches targeting A\u03b2 by using several synthetic and herbal compounds","author":"SK Singh","year":"2016","unstructured":"Singh SK, Srivastav S, Yadav AK, Srikrishna S, Perry G. Overview of Alzheimer\u2019s disease and some therapeutic approaches targeting A\u03b2 by using several synthetic and herbal compounds. Hindawi Publishing Corporation; 2016. https:\/\/doi.org\/10.1155\/2016\/7361613."},{"key":"982_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-27368-4","author":"AFJ Geraets","year":"2023","unstructured":"Geraets AFJ, Leist AK. Sex\/gender and socioeconomic differences in modifiable risk factors for dementia. Sci Rep. 2023. https:\/\/doi.org\/10.1038\/s41598-022-27368-4.","journal-title":"Sci Rep"},{"key":"982_CR12","doi-asserted-by":"publisher","unstructured":"Decourt B, D\u2019Souza GX, Shi J, et al. The cause of Alzheimer\u2019s disease: the theory of multipathology convergence to chronic neuronal stress. Aging Dis. 2022. https:\/\/doi.org\/10.14336\/AD.2021.0529.","DOI":"10.14336\/AD.2021.0529"},{"key":"982_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/s0197-4580(97)00056-0","author":"H Braak","year":"1997","unstructured":"Braak H, Braak E. Frequency of stages of Alzheimer-related lesions in different age categories. Neurobiol Aging. 1997. https:\/\/doi.org\/10.1016\/s0197-4580(97)00056-0.","journal-title":"Neurobiol Aging"},{"key":"982_CR14","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.58.12.1791","author":"DR Thal","year":"2002","unstructured":"Thal DR, R\u00fcb U, Orantes M, et al. Phases of A beta-deposition in the human brain and its relevance for the development of AD. Neurology. 2002. https:\/\/doi.org\/10.1212\/wnl.58.12.1791.","journal-title":"Neurology"},{"key":"982_CR15","doi-asserted-by":"publisher","DOI":"10.3978\/j.issn.2305-5839.2015.03.49","author":"W-Y Wang","year":"2015","unstructured":"Wang W-Y, Tan M-S, Yu J-T, et al. Role of pro-inflammatory cytokines released from microglia in Alzheimer\u2019s disease. Ann Transl Med. 2015. https:\/\/doi.org\/10.3978\/j.issn.2305-5839.2015.03.49.","journal-title":"Ann Transl Med"},{"key":"982_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41593-021-00951-0","author":"P d\u2019Errico","year":"2022","unstructured":"d\u2019Errico P, Ziegler-Waldkirch S, Aires V, et al. Microglia contribute to the propagation of A\u03b2 into unaffected brain tissue. Nat Neurosci. 2022. https:\/\/doi.org\/10.1038\/s41593-021-00951-0.","journal-title":"Nat Neurosci"},{"key":"982_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-022-00589-x","author":"DW Kim","year":"2022","unstructured":"Kim DW, Tu KJ, Wei A, et al. Amyloid-beta and tau pathologies act synergistically to induce novel disease stage-specific microglia subtypes. Mol Neurodegener. 2022. https:\/\/doi.org\/10.1186\/s13024-022-00589-x.","journal-title":"Mol Neurodegener"},{"key":"982_CR18","doi-asserted-by":"publisher","DOI":"10.1021\/acschemneuro.9b00037","author":"T Tripathi","year":"2019","unstructured":"Tripathi T, Kalita P. Synergistic effect of amyloid-\u03b2 and tau disrupts neural circuits. ACS Chem Neurosci. 2019. https:\/\/doi.org\/10.1021\/acschemneuro.9b00037.","journal-title":"ACS Chem Neurosci"},{"key":"982_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41593-020-0687-6","author":"MA Busche","year":"2020","unstructured":"Busche MA, Hyman BT. Synergy between amyloid-\u03b2 and tau in Alzheimer\u2019s disease. Nat Neurosci. 2020. https:\/\/doi.org\/10.1038\/s41593-020-0687-6.","journal-title":"Nat Neurosci"},{"key":"982_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.mito.2010.08.009","author":"L Tillement","year":"2011","unstructured":"Tillement L, Lecanu L, Papadopoulos V. Alzheimer\u2019s disease: effects of \u03b2-amyloid on mitochondria. Mitochondrion. 2011. https:\/\/doi.org\/10.1016\/j.mito.2010.08.009.","journal-title":"Mitochondrion"},{"key":"982_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2013.03.004","author":"J Park","year":"2013","unstructured":"Park J, Jang M, Chang S. Deleterious effects of soluble amyloid-\u03b2 oligomers on multiple steps of synaptic vesicle trafficking. Neurobiol Dis. 2013. https:\/\/doi.org\/10.1016\/j.nbd.2013.03.004.","journal-title":"Neurobiol Dis"},{"key":"982_CR22","doi-asserted-by":"publisher","DOI":"10.1515\/revneuro-2017-0063","author":"AB Reiss","year":"2018","unstructured":"Reiss AB, Arain HA, Stecker MM, et al. Amyloid toxicity in Alzheimer\u2019s disease. Rev Neurosci. 2018. https:\/\/doi.org\/10.1515\/revneuro-2017-0063.","journal-title":"Rev Neurosci"},{"key":"982_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/neuro.05.028.2009","author":"V Garcia-Marin","year":"2009","unstructured":"Garcia-Marin V, Blazquez-Llorca L, Rodriguez J, et al. Diminished perisomatic GABAergic terminals on cortical neurons adjacent to amyloid plaques. Front Neuroanat. 2009. https:\/\/doi.org\/10.3389\/neuro.05.028.2009.","journal-title":"Front Neuroanat"},{"key":"982_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22742-8","author":"JC Lauterborn","year":"2021","unstructured":"Lauterborn JC, Scaduto P, Cox CD, et al. Increased excitatory to inhibitory synaptic ratio in parietal cortex samples from individuals with Alzheimer\u2019s disease. Nat Commun. 2021. https:\/\/doi.org\/10.1038\/s41467-021-22742-8.","journal-title":"Nat Commun"},{"key":"982_CR25","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-022-02526-0","author":"P Scaduto","year":"2023","unstructured":"Scaduto P, Lauterborn JC, Cox CD, et al. Functional excitatory to inhibitory synaptic imbalance and loss of cognitive performance in people with Alzheimer\u2019s disease neuropathologic change. Acta Neuropathol. 2023. https:\/\/doi.org\/10.1007\/s00401-022-02526-0.","journal-title":"Acta Neuropathol"},{"key":"982_CR26","doi-asserted-by":"publisher","unstructured":"Busche MA, Chen X, Henning HA, et al. Critical role of soluble amyloid-\u03b2 for early hippocampal hyperactivity in a mouse model of Alzheimer\u2019s disease. Proc Natl Acad Sci U S A. 2012.https:\/\/doi.org\/10.1073\/pnas.1206171109.","DOI":"10.1073\/pnas.1206171109"},{"key":"982_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-71587-6","author":"KN Hascup","year":"2020","unstructured":"Hascup KN, Findley CA, Sime LN, et al. Hippocampal alterations in glutamatergic signaling during amyloid progression in A\u03b2PP\/PS1 mice. Sci Rep. 2020. https:\/\/doi.org\/10.1038\/s41598-020-71587-6.","journal-title":"Sci Rep"},{"key":"982_CR28","doi-asserted-by":"publisher","DOI":"10.1126\/science.aay0198","author":"B Zott","year":"2019","unstructured":"Zott B, Simon MM, Hong W, et al. A vicious cycle of \u03b2 amyloid\u2013dependent neuronal hyperactivation. Science. 2019. https:\/\/doi.org\/10.1126\/science.aay0198.","journal-title":"Science"},{"key":"982_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2021.101372","author":"F Maest\u00fa","year":"2021","unstructured":"Maest\u00fa F, de Haan W, Busche MA, et al. Neuronal excitation\/inhibition imbalance: core element of a translational perspective on Alzheimer pathophysiology. Ageing Res Rev. 2021. https:\/\/doi.org\/10.1016\/j.arr.2021.101372.","journal-title":"Ageing Res Rev"},{"key":"982_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/0022-510x(68)90154-8","author":"BE Tomlinson","year":"1968","unstructured":"Tomlinson BE, Blessed G, Roth M. Observations on the brains of non-demented old people. J Neurol Sci. 1968. https:\/\/doi.org\/10.1016\/0022-510x(68)90154-8.","journal-title":"J Neurol Sci"},{"key":"982_CR31","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.38.11.1682","author":"H Crystal","year":"1988","unstructured":"Crystal H, Dickson D, Fuld P, et al. Clinico-pathologic studies in dementia: nondemented subjects with pathologically confirmed Alzheimer\u2019s disease. Neurology. 1988. https:\/\/doi.org\/10.1212\/wnl.38.11.1682.","journal-title":"Neurology"},{"key":"982_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.dadm.2016.10.007","author":"SCJ Verfaillie","year":"2016","unstructured":"Verfaillie SCJ, Tijms B, Versteeg A, et al. Thinner temporal and parietal cortex is related to incident clinical progression to dementia in patients with subjective cognitive decline. Alzheimers Dement (Amst). 2016. https:\/\/doi.org\/10.1016\/j.dadm.2016.10.007.","journal-title":"Alzheimers Dement (Amst)"},{"key":"982_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-022-01685-6","author":"MM Michalowska","year":"2022","unstructured":"Michalowska MM, Herholz K, Hinz R, et al. Evaluation of in vivo staging of amyloid deposition in cognitively unimpaired elderly aged 78\u201394. Mol Psychiatry. 2022. https:\/\/doi.org\/10.1038\/s41380-022-01685-6.","journal-title":"Mol Psychiatry"},{"key":"982_CR34","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2021.5216","author":"WJ Jansen","year":"2022","unstructured":"Jansen WJ, Janssen O, Tijms BM, et al. Prevalence estimates of amyloid abnormality across the Alzheimer disease clinical spectrum. JAMA Neurol. 2022. https:\/\/doi.org\/10.1001\/jamaneurol.2021.5216.","journal-title":"JAMA Neurol"},{"key":"982_CR35","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e318245d295","author":"KM Rodrigue","year":"2012","unstructured":"Rodrigue KM, Kennedy KM, Devous MD, et al. \u03b2-Amyloid burden in healthy aging: regional distribution and cognitive consequences. Neurology. 2012. https:\/\/doi.org\/10.1212\/WNL.0b013e318245d295.","journal-title":"Neurology"},{"key":"982_CR36","doi-asserted-by":"publisher","DOI":"10.1001\/archneurol.2011.157","author":"JA Sonnen","year":"2011","unstructured":"Sonnen JA, Santa Cruz K, Hemmy LS, et al. Ecology of the aging human brain. Arch Neurol. 2011. https:\/\/doi.org\/10.1001\/archneurol.2011.157.","journal-title":"Arch Neurol"},{"key":"982_CR37","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.31126","author":"JA Miller","year":"2017","unstructured":"Miller JA, Guillozet-Bongaarts A, Gibbons LE, et al. Neuropathological and transcriptomic characteristics of the aged brain. eLife. 2017. https:\/\/doi.org\/10.7554\/eLife.31126.","journal-title":"eLife"},{"key":"982_CR38","doi-asserted-by":"publisher","DOI":"10.1001\/archneurol.2011.2748","author":"SM Landau","year":"2012","unstructured":"Landau SM, Marks SM, Mormino EC, et al. Association of lifetime cognitive engagement and low \u03b2-amyloid deposition. Arch Neurol. 2012. https:\/\/doi.org\/10.1001\/archneurol.2011.2748.","journal-title":"Arch Neurol"},{"key":"982_CR39","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000004425","author":"L Mosconi","year":"2017","unstructured":"Mosconi L, Berti V, Quinn C, et al. Sex differences in Alzheimer risk: brain imaging of endocrine vs chronologic aging. Neurology. 2017. https:\/\/doi.org\/10.1212\/WNL.0000000000004425.","journal-title":"Neurology"},{"key":"982_CR40","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-018-1920-1","author":"S Oveisgharan","year":"2018","unstructured":"Oveisgharan S, Arvanitakis Z, Yu L, et al. Sex differences in Alzheimer\u2019s disease and common neuropathologies of aging. Acta Neuropathol. 2018. https:\/\/doi.org\/10.1007\/s00401-018-1920-1.","journal-title":"Acta Neuropathol"},{"key":"982_CR41","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2018.4693","author":"RF Buckley","year":"2019","unstructured":"Buckley RF, Mormino EC, Rabin JS, et al. Sex differences in the association of global amyloid and regional tau deposition measured by positron emission tomography in clinically normal older adults. JAMA Neurol. 2019. https:\/\/doi.org\/10.1001\/jamaneurol.2018.4693.","journal-title":"JAMA Neurol"},{"key":"982_CR42","doi-asserted-by":"publisher","DOI":"10.1093\/gerona\/glz235","author":"M Joannette","year":"2020","unstructured":"Joannette M, Bocti C, Dupont PS, et al. Education as a moderator of the relationship between episodic memory and amyloid load in normal Aging. J Gerontol A Biol Sci Med Sci. 2020. https:\/\/doi.org\/10.1093\/gerona\/glz235.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"982_CR43","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.59.11.1737","author":"WA Kukull","year":"2002","unstructured":"Kukull WA, Higdon R, Bowen JD, et al. Dementia and Alzheimer disease incidence: a prospective cohort study. Arch Neurol. 2002. https:\/\/doi.org\/10.1001\/archneur.59.11.1737.","journal-title":"Arch Neurol"},{"key":"982_CR44","doi-asserted-by":"publisher","DOI":"10.1017\/s1041610294001602","author":"EL Teng","year":"1994","unstructured":"Teng EL, Hasegawa K, Homma A, et al. The cognitive abilities screening instrument (CASI): a practical test for cross-cultural epidemiological studies of dementia. Int Psychogeriatr. 1994. https:\/\/doi.org\/10.1017\/s1041610294001602.","journal-title":"Int Psychogeriatr"},{"key":"982_CR45","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.34.7.939","author":"G McKhann","year":"1984","unstructured":"McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer\u2019s disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer\u2019s Disease. Neurology. 1984. https:\/\/doi.org\/10.1212\/wnl.34.7.939.","journal-title":"Neurology"},{"key":"982_CR46","first-page":"886","volume-title":"Task Force on DSM-IV. Diagnostic and statistical manual of mental disorders: DSM-IV","author":"American Psychiatric Association","year":"1994","unstructured":"American Psychiatric Association. Task Force on DSM-IV. Diagnostic and statistical manual of mental disorders: DSM-IV. 4th ed. Washington, DC: American Psychiatric Association, Inc; 1994. p. 886.","edition":"4"},{"key":"982_CR47","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11030770","author":"Z Amro","year":"2023","unstructured":"Amro Z, Ryan M, Collins-Praino LE, et al. Unexpected classes of aquaporin channels detected by transcriptomic analysis in human brain are associated with both patient age and Alzheimer\u2019s disease status. Biomedicines. 2023. https:\/\/doi.org\/10.3390\/biomedicines11030770.","journal-title":"Biomedicines"},{"key":"982_CR48","doi-asserted-by":"publisher","DOI":"10.1089\/ars.2005.7.269","author":"TJ Montine","year":"2005","unstructured":"Montine TJ, Montine KS, McMahan W, et al. F2-isoprostanes in Alzheimer and other neurodegenerative diseases. Antioxid redox signal. 2005. https:\/\/doi.org\/10.1089\/ars.2005.7.269.","journal-title":"Antioxid redox signal"},{"key":"982_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchromb.2005.03.037","author":"D Milatovic","year":"2005","unstructured":"Milatovic D, VanRollins M, Li K, et al. Suppression of murine cerebral F2-isoprostanes and F4-neuroprostanes from excitotoxicity and innate immune response in vivo by alpha- or gamma-tocopherol. J Chromatogr B Analyt Technol Biomed Life Sci. 2005. https:\/\/doi.org\/10.1016\/j.jchromb.2005.03.037.","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"982_CR50","volume-title":"Unbiased stereology: three-dimensional measurement in microscopy","author":"V Howard","year":"2005","unstructured":"Howard V, Reed N. Unbiased stereology: three-dimensional measurement in microscopy. 2nd ed. Oxon: Garland Science; 2005.","edition":"2"},{"key":"982_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychires.2018.02.008","author":"Y Stephan","year":"2018","unstructured":"Stephan Y, Sutin AR, Luchetti M, et al. Subjective age and risk of incident dementia: evidence from the national health and aging trends survey. J Psychiatr Res. 2018. https:\/\/doi.org\/10.1016\/j.jpsychires.2018.02.008.","journal-title":"J Psychiatr Res"},{"key":"982_CR52","doi-asserted-by":"publisher","unstructured":"Alzheimer\u2019s Association. Alzheimer\u2019s disease facts and figures. 2022. https:\/\/doi.org\/10.1002\/alz.12638","DOI":"10.1002\/alz.12638"},{"key":"982_CR53","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000003425","author":"GN Bischof","year":"2016","unstructured":"Bischof GN, Rodrigue KM, Kennedy KM, et al. Amyloid deposition in younger adults is linked to episodic memory performance. Neurology. 2016. https:\/\/doi.org\/10.1212\/WNL.0000000000003425.","journal-title":"Neurology"},{"key":"982_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2009.04.002","author":"JL Price","year":"2009","unstructured":"Price JL, McKeel DW, Buckles VD, et al. Neuropathology of nondemented aging: presumptive evidence for preclinical Alzheimer disease. Neurobiol Aging. 2009. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2009.04.002.","journal-title":"Neurobiol Aging"},{"key":"982_CR55","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-018-1908-x","author":"AM Liesinger","year":"2018","unstructured":"Liesinger AM, Graff-Radford NR, Duara R, et al. Sex and age interact to determine clinicopathologic differences in Alzheimer\u2019s disease. Acta Neuropathol. 2018. https:\/\/doi.org\/10.1007\/s00401-018-1908-x.","journal-title":"Acta Neuropathol"},{"key":"982_CR56","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-180141","author":"CR Beam","year":"2018","unstructured":"Beam CR, Kaneshiro C, Jang JY, et al. Differences between women and men in incidence rates of dementia and Alzheimer\u2019s disease. J Alzheimers Dis. 2018. https:\/\/doi.org\/10.3233\/JAD-180141.","journal-title":"J Alzheimers Dis"},{"key":"982_CR57","doi-asserted-by":"publisher","first-page":"S527","DOI":"10.3233\/JAD-2010-100501","volume":"S520","author":"J Vina","year":"2010","unstructured":"Vina J, Lloret A. Why women have more Alzheimer\u2019s disease than men: gender and mitochondrial toxicity of amyloid-beta peptide. J Alzheimers Dis. 2010;S520:S527\u201333.","journal-title":"J Alzheimers Dis"},{"key":"982_CR58","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-018-1881-4","author":"Y Deming","year":"2018","unstructured":"Deming Y, Dumitrescu L, Barnes LL, et al. Sex-specific genetic predictors of Alzheimer\u2019s disease biomarkers. Acta Neuropathol. 2018. https:\/\/doi.org\/10.1007\/s00401-018-1881-4.","journal-title":"Acta Neuropathol"},{"key":"982_CR59","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e31826e2696","author":"MM Mielke","year":"2012","unstructured":"Mielke MM, Wiste HJ, Weigand SD, et al. Indicators of amyloid burden in a population-based study of cognitively normal elderly. Neurology. 2012. https:\/\/doi.org\/10.1212\/WNL.0b013e31826e2696.","journal-title":"Neurology"},{"key":"982_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2018.04.010","author":"RF Buckley","year":"2018","unstructured":"Buckley RF, Mormino EC, Amariglio RE, et al. Sex, amyloid, and APOE \u03b54 and risk of cognitive decline in preclinical Alzheimer\u2019s disease: findings from three well-characterized cohorts. Alzheimer\u2019s Dement. 2018. https:\/\/doi.org\/10.1016\/j.jalz.2018.04.010.","journal-title":"Alzheimer\u2019s Dement"},{"key":"982_CR61","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-191183","author":"JA Luchsinger","year":"2020","unstructured":"Luchsinger JA, Palta P, Rippon B, et al. Sex differences in in-vivo Alzheimer\u2019s disease neuropathology in late middle-aged Hispanics. J Alzheimers Dis. 2020. https:\/\/doi.org\/10.3233\/JAD-191183.","journal-title":"J Alzheimers Dis"},{"key":"982_CR62","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.62.6.685","author":"LL Barnes","year":"2005","unstructured":"Barnes LL, Wilson RS, Bienias JL, et al. Sex differences in the clinical manifestations of Alzheimer disease pathology. Arch Gen Psychiatry. 2005. https:\/\/doi.org\/10.1001\/archpsyc.62.6.685.","journal-title":"Arch Gen Psychiatry"},{"key":"982_CR63","doi-asserted-by":"publisher","DOI":"10.1111\/nan.12729","author":"Y-T Hu","year":"2021","unstructured":"Hu Y-T, Boonstra J, McGurran H, et al. Sex differences in the neuropathological hallmarks of Alzheimer\u2019s disease: focus on cognitively intact elderly individuals. 2021. Neuropathol Appl Neurobiol. https:\/\/doi.org\/10.1111\/nan.12729.","journal-title":"Neuropathol Appl Neurobiol"},{"key":"982_CR64","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.2718-07.2007","author":"JC Carroll","year":"2007","unstructured":"Carroll JC, Rosario ER, Chang L, et al. Progesterone and estrogen regulate Alzheimer-like neuropathology in female 3xTg-AD mice. J Neurosci. 2007. https:\/\/doi.org\/10.1523\/JNEUROSCI.2718-07.2007.","journal-title":"J Neurosci"},{"key":"982_CR65","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2023.1117584","author":"Y-T Hu","year":"2023","unstructured":"Hu Y-T, Chen X-L, Zhang Y-N, et al. Sex differences in hippocampal \u03b2-amyloid accumulation in the triple-transgenic mouse model of Alzheimer\u2019s disease and the potential role of local estrogens. Front Neurosci. 2023. https:\/\/doi.org\/10.3389\/fnins.2023.1117584.","journal-title":"Front Neurosci"},{"key":"982_CR66","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2021.09.004","author":"LA Demetrius","year":"2021","unstructured":"Demetrius LA, Eckert A, Grimm A. Sex differences in Alzheimer\u2019s disease: metabolic reprogramming and therapeutic intervention. Trends Endocrinol Metab. 2021. https:\/\/doi.org\/10.1016\/j.tem.2021.09.004.","journal-title":"Trends Endocrinol Metab"},{"key":"982_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2011.03.001","author":"J Yao","year":"2012","unstructured":"Yao J, Irwin R, Chen S, et al. Ovarian hormone loss induces bioenergetic deficits and mitochondrial \u03b2-amyloid. Neurobiol Aging. 2012. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2011.03.001.","journal-title":"Neurobiol Aging"},{"key":"982_CR68","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2010.05.031","author":"Z Amtul","year":"2010","unstructured":"Amtul Z, Wang L, Westaway D, et al. Neuroprotective mechanism conferred by 17beta-estradiol on the biochemical basis of Alzheimer\u2019s disease. Neuroscience. 2010. https:\/\/doi.org\/10.1016\/j.neuroscience.2010.05.031.","journal-title":"Neuroscience"},{"key":"982_CR69","doi-asserted-by":"publisher","unstructured":"Belleville S, Mellah S, Cloutier S, et al. Neural correlates of resilience to the effects of hippocampal atrophy on memory. NeuroImage: Clinical 2021. https:\/\/doi.org\/10.1016\/j.nicl.2020.102526.","DOI":"10.1016\/j.nicl.2020.102526"},{"key":"982_CR70","doi-asserted-by":"publisher","DOI":"10.3390\/cells11244033","author":"CCM Castro","year":"2022","unstructured":"Castro CCM, Silva SP, Rabelo LN, et al. Age, education years, and biochemical factors are associated with selective neuronal changes in the elderly hippocampus. Cells. 2022. https:\/\/doi.org\/10.3390\/cells11244033.","journal-title":"Cells"},{"issue":"3","key":"982_CR71","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1017\/S1355617702813248","volume":"8","author":"Y Stern","year":"2002","unstructured":"Stern Y. What is cognitive reserve? Theory and research application of the reserve concept. J Int Neuropsychol Soc. 2002;8(3):448\u201360.","journal-title":"J Int Neuropsychol Soc"},{"key":"982_CR72","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2018.07.219","author":"Y Stern","year":"2020","unstructured":"Stern Y, Arenaza-Urquijo EM, Bartr\u00e9s-Faz D, et al. Whitepaper: defining and investigating cognitive reserve, brain reserve, and brain maintenance. Alzheimer\u2019s Dement. 2020. https:\/\/doi.org\/10.1016\/j.jalz.2018.07.219.","journal-title":"Alzheimer\u2019s Dement"},{"key":"982_CR73","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2022.05.015","author":"E Ersoezlue","year":"2023","unstructured":"Ersoezlue E, Rauchmann B-S, Schneider-Axmann T, et al. Lifelong experiences as a proxy of cognitive reserve moderate the association between connectivity and cognition in Alzheimer\u2019s disease. Neurobiol Aging. 2023. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2022.05.015.","journal-title":"Neurobiol Aging"},{"key":"982_CR74","doi-asserted-by":"publisher","DOI":"10.1016\/j.breast.2022.07.013","author":"S Liesto","year":"2022","unstructured":"Liesto S, Sipil\u00e4 R, Hietanen M, et al. Cognitive function is well preserved in a cohort of breast cancer survivors: roles of cognitive reserve, resilience, and general health. The Breast. 2022. https:\/\/doi.org\/10.1016\/j.breast.2022.07.013.","journal-title":"The Breast"},{"key":"982_CR75","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2022.114479","author":"M Rodriguez","year":"2022","unstructured":"Rodriguez M, Kn\u00ed\u017ekov\u00e1 K, Ke\u0159kov\u00e1 B, et al. The relationships between cognitive reserve, cognitive functioning and quality of life in first-episode schizophrenia spectrum disorders. Psychiatry Res. 2022. https:\/\/doi.org\/10.1016\/j.psychres.2022.114479.","journal-title":"Psychiatry Res"},{"key":"982_CR76","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2023.01.012","author":"EK Brenner","year":"2023","unstructured":"Brenner EK, Thomas KR, Weigand AJ, et al. Cognitive reserve moderates the association between cerebral blood flow and language performance in older adults with mild cognitive impairment. Neurobiol Aging. 2023. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2023.01.012.","journal-title":"Neurobiol Aging"},{"key":"982_CR77","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2022.101814","author":"I Contador","year":"2023","unstructured":"Contador I, Alzola P, Stern Y, et al. Is cognitive reserve associated with the prevention of cognitive decline after stroke? A systematic review and meta-analysis. Ageing Res Rev. 2023. https:\/\/doi.org\/10.1016\/j.arr.2022.101814.","journal-title":"Ageing Res Rev"},{"key":"982_CR78","doi-asserted-by":"publisher","DOI":"10.1002\/alz.12899","author":"M Zhang","year":"2023","unstructured":"Zhang M, Ganz AB, Rohde S, et al. Resilience and resistance to the accumulation of amyloid plaques and neurofibrillary tangles in centenarians: an age-continuous perspective. Alzheimers Dement. 2023. https:\/\/doi.org\/10.1002\/alz.12899.","journal-title":"Alzheimers Dement"},{"key":"982_CR79","doi-asserted-by":"publisher","DOI":"10.1038\/s41431-018-0273-5","author":"N Tesi","year":"2019","unstructured":"Tesi N, van der Lee SJ, Hulsman M, et al. Centenarian controls increase variant effect sizes by an average twofold in an extreme case\u2013extreme control analysis of Alzheimer\u2019s disease. Eur J Hum Genet. 2019. https:\/\/doi.org\/10.1038\/s41431-018-0273-5.","journal-title":"Eur J Hum Genet"},{"key":"982_CR80","doi-asserted-by":"publisher","DOI":"10.1007\/s10654-018-0451-3","author":"H Holstege","year":"2018","unstructured":"Holstege H, Beker N, Dijkstra T, et al. The 100-plus study of cognitively healthy centenarians: rationale, design and cohort description. Eur J Epidemiol. 2018. https:\/\/doi.org\/10.1007\/s10654-018-0451-3.","journal-title":"Eur J Epidemiol"},{"key":"982_CR81","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.31654","author":"N Beker","year":"2021","unstructured":"Beker N, Ganz A, Hulsman M, et al. Association of cognitive function trajectories in centenarians with postmortem neuropathology, physical health, and other risk factors for cognitive decline. JAMA Netw Open. 2021. https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.31654.","journal-title":"JAMA Netw Open"},{"key":"982_CR82","doi-asserted-by":"publisher","DOI":"10.1002\/ana.21904","author":"DM Rentz","year":"2010","unstructured":"Rentz DM, Locascio JJ, Becker JA, et al. Cognition, reserve, and amyloid deposition in normal aging. Ann Neurol. 2010. https:\/\/doi.org\/10.1002\/ana.21904.","journal-title":"Ann Neurol"},{"key":"982_CR83","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2017.3391","author":"WJ Jansen","year":"2018","unstructured":"Jansen WJ, Ossenkoppele R, Tijms BM, et al. Association of cerebral amyloid-\u03b2 aggregation with cognitive functioning in persons without dementia. JAMA Psychiat. 2018. https:\/\/doi.org\/10.1001\/jamapsychiatry.2017.3391.","journal-title":"JAMA Psychiat"},{"key":"982_CR84","doi-asserted-by":"publisher","DOI":"10.1002\/gps.4235","author":"F Yasuno","year":"2015","unstructured":"Yasuno F, Kazui H, Morita N, et al. Low amyloid-\u03b2 deposition correlates with high education in cognitively normal older adults: a pilot study. Int J Geriatr Psychiatry. 2015. https:\/\/doi.org\/10.1002\/gps.4235.","journal-title":"Int J Geriatr Psychiatry"},{"key":"982_CR85","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2017.06.016","author":"EM Arenaza-Urquijo","year":"2017","unstructured":"Arenaza-Urquijo EM, Bejanin A, Gonneaud J, et al. Association between educational attainment and amyloid deposition across the spectrum from normal cognition to dementia: neuroimaging evidence for protection and compensation. Neurobiol Aging. 2017. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2017.06.016.","journal-title":"Neurobiol Aging"},{"key":"982_CR86","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-171168","author":"M Wada","year":"2018","unstructured":"Wada M, Noda Y, Shinagawa S, et al. Effect of education on Alzheimer\u2019s disease-related neuroimaging biomarkers in healthy controls, and participants with mild cognitive impairment and Alzheimer\u2019s disease: a cross-sectional study. J Alzheimers Dis. 2018. https:\/\/doi.org\/10.3233\/JAD-171168.","journal-title":"J Alzheimers Dis"},{"key":"982_CR87","doi-asserted-by":"publisher","DOI":"10.1097\/NEN.0000000000000016","author":"A Serrano-Pozo","year":"2013","unstructured":"Serrano-Pozo A, Qian J, Monsell SE, et al. Examination of the clinicopathologic continuum of Alzheimer disease in the autopsy cohort of the national Alzheimer coordinating center. J Neuropathol Exp Neurol. 2013. https:\/\/doi.org\/10.1097\/NEN.0000000000000016.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"supplement 2","key":"982_CR88","first-page":"2609","volume":"63","author":"M Hoenig","year":"2022","unstructured":"Hoenig M, Caprioglio CC, Collij L, et al. Inverse relationship between education and amyloid burden in individuals with subjective cognitive decline plus and mild cognitive impairment. J Nucl Med. 2022;63(supplement 2):2609\u20132609.","journal-title":"J Nucl Med"},{"key":"982_CR89","doi-asserted-by":"publisher","DOI":"10.1002\/ana.21212","author":"NM Kemppainen","year":"2008","unstructured":"Kemppainen NM, Aalto S, Karrasch M, et al. Cognitive reserve hypothesis: Pittsburgh compound B and fluorodeoxyglucose positron emission tomography in relation to education in mild Alzheimer\u2019s disease. Ann Neurol. 2008. https:\/\/doi.org\/10.1002\/ana.21212.","journal-title":"Ann Neurol"},{"key":"982_CR90","doi-asserted-by":"publisher","DOI":"10.1007\/s00429-022-02503-z","author":"KG Schilling","year":"2022","unstructured":"Schilling KG, Archer D, Yeh F-C, et al. Aging and white matter microstructure and macrostructure: a longitudinal multi-site diffusion MRI study of 1218 participants. Brain struct funct. 2022. https:\/\/doi.org\/10.1007\/s00429-022-02503-z.","journal-title":"Brain struct funct"},{"key":"982_CR91","doi-asserted-by":"publisher","DOI":"10.1007\/s00429-023-02642-x","author":"KG Schilling","year":"2023","unstructured":"Schilling KG, Archer D, Rheault F, et al. Superficial white matter across development, young adulthood, and aging: volume, thickness, and relationship with cortical features. Brain struct funct. 2023. https:\/\/doi.org\/10.1007\/s00429-023-02642-x.","journal-title":"Brain struct funct"},{"key":"982_CR92","doi-asserted-by":"publisher","DOI":"10.1002\/hbm.21334","author":"AM Hedman","year":"2012","unstructured":"Hedman AM, van Haren NEM, Schnack HG, et al. Human brain changes across the life span: a review of 56 longitudinal magnetic resonance imaging studies. Hum brain mapp. 2012. https:\/\/doi.org\/10.1002\/hbm.21334.","journal-title":"Hum brain mapp"},{"key":"982_CR93","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2011.11.094","author":"C Lebel","year":"2012","unstructured":"Lebel C, Gee M, Camicioli R, et al. Diffusion tensor imaging of white matter tract evolution over the lifespan. Neuroimage. 2012. https:\/\/doi.org\/10.1016\/j.neuroimage.2011.11.094.","journal-title":"Neuroimage"},{"key":"982_CR94","doi-asserted-by":"publisher","unstructured":"Bethlehem RaI, Seidlitz J, White SR, et al. Brain charts for the human lifespan. Nature. 2022. https:\/\/doi.org\/10.1038\/s41586-022-04554-y.","DOI":"10.1038\/s41586-022-04554-y"},{"key":"982_CR95","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-014-0083-0","author":"LE Collins-Praino","year":"2014","unstructured":"Collins-Praino LE, Francis YI, Griffith EY, et al. Soluble amyloid beta levels are elevated in the white matter of Alzheimer\u2019s patients, independent of cortical plaque severity. Acta Neuropathol Commun. 2014. https:\/\/doi.org\/10.1186\/s40478-014-0083-0.","journal-title":"Acta Neuropathol Commun"},{"key":"982_CR96","doi-asserted-by":"publisher","DOI":"10.1002\/alz.12062","author":"M\u00c1A Caballero","year":"2020","unstructured":"Caballero M\u00c1A, Song Z, Rubinski A, et al. Age-dependent amyloid deposition is associated with white matter alterations in cognitively normal adults during the adult life span. Alzheimers Dement. 2020. https:\/\/doi.org\/10.1002\/alz.12062.","journal-title":"Alzheimers Dement"},{"key":"982_CR97","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awz162","author":"J Graff-Radford","year":"2019","unstructured":"Graff-Radford J, Arenaza-Urquijo EM, Knopman DS, et al. White matter hyperintensities: relationship to amyloid and tau burden. Brain. 2019. https:\/\/doi.org\/10.1093\/brain\/awz162.","journal-title":"Brain"},{"key":"982_CR98","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2019.08.025","author":"PS Dupont","year":"2020","unstructured":"Dupont PS, Bocti C, Joannette M, et al. Amyloid burden and white matter hyperintensities mediate age-related cognitive differences. Neurobiol Aging. 2020. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2019.08.025.","journal-title":"Neurobiol Aging"},{"key":"982_CR99","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.121.022087","author":"KA Walker","year":"2021","unstructured":"Walker KA, Silverstein N, Zhou Y, et al. Brain white matter structure and amyloid deposition in black and white older adults: the ARIC-PET study. J Am Heart Assoc. 2021. https:\/\/doi.org\/10.1161\/JAHA.121.022087.","journal-title":"J Am Heart Assoc"},{"key":"982_CR100","doi-asserted-by":"publisher","DOI":"10.1016\/j.nicl.2023.103383","author":"SL Alban","year":"2023","unstructured":"Alban SL, Lynch KM, Ringman JM, et al. The association between white matter hyperintensities and amyloid and tau deposition. Neuroimage Clin. 2023. https:\/\/doi.org\/10.1016\/j.nicl.2023.103383.","journal-title":"Neuroimage Clin"},{"key":"982_CR101","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-023-00640-5","author":"Y Inoue","year":"2023","unstructured":"Inoue Y, Shue F, Bu G, et al. Pathophysiology and probable etiology of cerebral small vessel disease in vascular dementia and Alzheimer\u2019s disease. Mol Neurodegener. 2023. https:\/\/doi.org\/10.1186\/s13024-023-00640-5.","journal-title":"Mol Neurodegener"},{"key":"982_CR102","doi-asserted-by":"publisher","DOI":"10.1161\/01.str.14.6.915","author":"JJ Gilbert","year":"1983","unstructured":"Gilbert JJ, Vinters HV. Cerebral amyloid angiopathy: incidence and complications in the aging brain. I. Cerebral hemorrhage. Stroke. 1983. https:\/\/doi.org\/10.1161\/01.str.14.6.915.","journal-title":"Stroke"},{"key":"982_CR103","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000000732","author":"S Thanprasertsuk","year":"2014","unstructured":"Thanprasertsuk S, Martinez-Ramirez S, Pontes-Neto OM, et al. Posterior white matter disease distribution as a predictor of amyloid angiopathy. Neurology. 2014. https:\/\/doi.org\/10.1212\/WNL.0000000000000732.","journal-title":"Neurology"},{"key":"982_CR104","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci12111445","author":"H Zheng","year":"2022","unstructured":"Zheng H, Yuan Y, Zhang Z, et al. Analysis of risk factors for cerebral microbleeds and the relationship between cerebral microbleeds and cognitive impairment. Brain Sci. 2022. https:\/\/doi.org\/10.3390\/brainsci12111445.","journal-title":"Brain Sci"},{"key":"982_CR105","doi-asserted-by":"publisher","unstructured":"Chai AB, Lam HHJ, Kockx M, et al. Apolipoprotein E isoform-dependent effects on the processing of Alzheimer\u2019s amyloid-\u03b2. Biochim Biophys Acta (BBA) \u2013 Mol Cell Biol Lipids. 2021. https:\/\/doi.org\/10.1016\/j.bbalip.2021.158980.","DOI":"10.1016\/j.bbalip.2021.158980"},{"key":"982_CR106","doi-asserted-by":"publisher","unstructured":"Murphy MP, LeVine H. Alzheimer\u2019s disease and the amyloid-\u03b2 peptide. Lovell MA. ed. JAD. 2010.https:\/\/doi.org\/10.3233\/JAD-2010-1221.","DOI":"10.3233\/JAD-2010-1221"},{"key":"982_CR107","doi-asserted-by":"publisher","unstructured":"Steiner H, Fukumori A, Tagami S, et al. Making the final cut: pathogenic amyloid-\u03b2 peptide generation by \u03b3-secretase. CST. 2018. https:\/\/doi.org\/10.15698\/cst2018.11.162.","DOI":"10.15698\/cst2018.11.162"},{"key":"982_CR108","doi-asserted-by":"publisher","DOI":"10.1016\/0896-6273(94)90458-8","author":"T Iwatsubo","year":"1994","unstructured":"Iwatsubo T, Odaka A, Suzuki N, et al. Visualization of A\u03b242(43) and A\u03b240 in senile plaques with end-specific A\u03b2 monoclonals: evidence that an initially deposited species is A\u03b242(43). Neuron. 1994. https:\/\/doi.org\/10.1016\/0896-6273(94)90458-8.","journal-title":"Neuron"},{"key":"982_CR109","doi-asserted-by":"publisher","DOI":"10.1016\/0197-4580(96)00062-0","author":"BJ Cummings","year":"1996","unstructured":"Cummings BJ, Satou T, Head E, et al. Diffuse plaques contain C-terminal a beta 42 and not a beta 40: evidence from cats and dogs. Neurobiol Aging. 1996. https:\/\/doi.org\/10.1016\/0197-4580(96)00062-0.","journal-title":"Neurobiol Aging"},{"key":"982_CR110","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1202753","author":"RJ Bateman","year":"2012","unstructured":"Bateman RJ, Xiong C, Benzinger TLS, et al. Clinical and biomarker changes in dominantly inherited Alzheimer\u2019s disease. N Engl J Med. 2012. https:\/\/doi.org\/10.1056\/NEJMoa1202753.","journal-title":"N Engl J Med"},{"key":"982_CR111","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2017.03.011","author":"RE Bennett","year":"2017","unstructured":"Bennett RE, DeVos SL, Dujardin S, et al. Enhanced tau aggregation in the presence of amyloid \u03b2. Am J Pathol. 2017. https:\/\/doi.org\/10.1016\/j.ajpath.2017.03.011.","journal-title":"Am J Pathol"},{"key":"982_CR112","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2013.5847","author":"GS Bloom","year":"2014","unstructured":"Bloom GS. Amyloid-\u03b2 and tau: the trigger and bullet in Alzheimer disease pathogenesis. JAMA Neurol. 2014. https:\/\/doi.org\/10.1001\/jamaneurol.2013.5847.","journal-title":"JAMA Neurol"},{"key":"982_CR113","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4443","author":"Z He","year":"2018","unstructured":"He Z, Guo JL, McBride JD, et al. Amyloid-\u03b2 plaques enhance Alzheimer\u2019s brain tau-seeded pathologies by facilitating neuritic plaque tau aggregation. Nat Med. 2018. https:\/\/doi.org\/10.1038\/nm.4443.","journal-title":"Nat Med"},{"key":"982_CR114","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(20)30071-5","author":"TK Karikari","year":"2020","unstructured":"Karikari TK, Pascoal TA, Ashton NJ, et al. Blood phosphorylated tau 181 as a biomarker for Alzheimer\u2019s disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts. Lancet Neurol. 2020. https:\/\/doi.org\/10.1016\/S1474-4422(20)30071-5.","journal-title":"Lancet Neurol"},{"key":"982_CR115","doi-asserted-by":"publisher","DOI":"10.1007\/s11357-015-9867-9","author":"FP Fiuza","year":"2016","unstructured":"Fiuza FP, Silva KDA, Pessoa RA, et al. Age-related changes in neurochemical components and retinal projections of rat intergeniculate leaflet. Age (Dordr). 2016. https:\/\/doi.org\/10.1007\/s11357-015-9867-9.","journal-title":"Age (Dordr)"},{"key":"982_CR116","doi-asserted-by":"publisher","DOI":"10.1016\/j.exger.2017.11.001","author":"FP Fiuza","year":"2017","unstructured":"Fiuza FP, Aquino ACQ, C\u00e2mara DA, et al. Region-specific glial hyperplasia and neuronal stability of rat lateral geniculate nucleus during aging. Exp Gerontol. 2017. https:\/\/doi.org\/10.1016\/j.exger.2017.11.001.","journal-title":"Exp Gerontol"},{"key":"982_CR117","doi-asserted-by":"publisher","unstructured":"Engelberth RCGJ, Silva KD de A, Fiuza FP, et al. Retinal, NPY- and 5ht- inputs to the aged suprachiasmatic nucleus in common marmosets (Callithrix jacchus). Neurosci Res. 2017;121:54\u201359. https:\/\/doi.org\/10.1016\/j.neures.2017.03.005.","DOI":"10.1016\/j.neures.2017.03.005"},{"key":"982_CR118","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0234255","author":"X Feng","year":"2020","unstructured":"Feng X, Guo J, Sigmon HC, et al. Brain regions vulnerable and resistant to aging without Alzheimer\u2019s disease. PLoS One. 2020. https:\/\/doi.org\/10.1371\/journal.pone.0234255.","journal-title":"PLoS One"},{"key":"982_CR119","doi-asserted-by":"publisher","DOI":"10.3390\/life13041053","author":"AS Bader","year":"2023","unstructured":"Bader AS, Gn\u00e4dig M-U, Fricke M, et al. Brain region-specific differences in amyloid-\u03b2 plaque composition in 5XFAD mice. Life (Basel). 2023. https:\/\/doi.org\/10.3390\/life13041053.","journal-title":"Life (Basel)"},{"key":"982_CR120","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2023.1032504","author":"S Das","year":"2023","unstructured":"Das S, Ramanan N. Region-specific heterogeneity in neuronal nuclear morphology in young, aged and in Alzheimer\u2019s disease mouse brains. Front Cell Dev Biol. 2023. https:\/\/doi.org\/10.3389\/fcell.2023.1032504.","journal-title":"Front Cell Dev Biol"},{"key":"982_CR121","doi-asserted-by":"publisher","DOI":"10.1080\/13550280290100969","author":"PL McGeer","year":"2002","unstructured":"McGeer PL, McGeer EG. Local neuroinflammation and the progression of Alzheimer\u2019s disease. J Neurovirol. 2002. https:\/\/doi.org\/10.1080\/13550280290100969.","journal-title":"J Neurovirol"},{"key":"982_CR122","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24031869","author":"FL Andronie-Cioara","year":"2023","unstructured":"Andronie-Cioara FL, Ardelean AI, Nistor-Cseppento CD, et al. Molecular mechanisms of neuroinflammation in aging and Alzheimer\u2019s disease progression. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms24031869.","journal-title":"Int J Mol Sci"},{"key":"982_CR123","doi-asserted-by":"publisher","DOI":"10.1016\/j.imlet.2008.02.002","author":"P Bermejo","year":"2008","unstructured":"Bermejo P, Mart\u00edn-Arag\u00f3n S, Bened\u00ed J, et al. Differences of peripheral inflammatory markers between mild cognitive impairment and Alzheimer\u2019s disease. Immunol Lett. 2008. https:\/\/doi.org\/10.1016\/j.imlet.2008.02.002.","journal-title":"Immunol Lett"},{"key":"982_CR124","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-2-9","author":"NS Patel","year":"2005","unstructured":"Patel NS, Paris D, Mathura V, et al. Inflammatory cytokine levels correlate with amyloid load in transgenic mouse models of Alzheimer\u2019s disease. J Neuroinflammation. 2005. https:\/\/doi.org\/10.1186\/1742-2094-2-9.","journal-title":"J Neuroinflammation"},{"key":"982_CR125","doi-asserted-by":"publisher","DOI":"10.2353\/ajpath.2007.060378","author":"M Yamamoto","year":"2007","unstructured":"Yamamoto M, Kiyota T, Horiba M, et al. Interferon-gamma and tumor necrosis factor-alpha regulate amyloid-beta plaque deposition and beta-secretase expression in Swedish mutant APP transgenic mice. Am J Pathol. 2007. https:\/\/doi.org\/10.2353\/ajpath.2007.060378.","journal-title":"Am J Pathol"},{"key":"982_CR126","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcaa146","author":"DR Whiten","year":"2020","unstructured":"Whiten DR, Brownjohn PW, Moore S, et al. Tumour necrosis factor induces increased production of extracellular amyloid-\u03b2- and \u03b1-synuclein-containing aggregates by human Alzheimer\u2019s disease neurons. Brain Commun. 2020. https:\/\/doi.org\/10.1093\/braincomms\/fcaa146.","journal-title":"Brain Commun"},{"key":"982_CR127","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2010.10.053","author":"J-Q Shi","year":"2011","unstructured":"Shi J-Q, Shen W, Chen J, et al. Anti-TNF-\u03b1 reduces amyloid plaques and tau phosphorylation and induces CD11c-positive dendritic-like cell in the APP\/PS1 transgenic mouse brains. Brain Res. 2011. https:\/\/doi.org\/10.1016\/j.brainres.2010.10.053.","journal-title":"Brain Res"},{"key":"982_CR128","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcyt.2019.04.054","author":"J Park","year":"2019","unstructured":"Park J, Lee S-Y, Shon J, et al. Adalimumab improves cognitive impairment, exerts neuroprotective effects and attenuates neuroinflammation in an A\u03b21-40-injected mouse model of Alzheimer\u2019s disease. Cytotherapy. 2019. https:\/\/doi.org\/10.1016\/j.jcyt.2019.04.054.","journal-title":"Cytotherapy"},{"issue":"2","key":"982_CR129","first-page":"25","volume":"8","author":"E Tobinick","year":"2006","unstructured":"Tobinick E, Gross H, Weinberger A, et al. TNF-alpha modulation for treatment of Alzheimer\u2019s disease: a 6-month pilot study. MedGenMed. 2006;8(2):25.","journal-title":"MedGenMed"}],"container-title":["GeroScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11357-023-00982-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11357-023-00982-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11357-023-00982-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,30]],"date-time":"2024-01-30T08:36:28Z","timestamp":1706603788000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11357-023-00982-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,23]]},"references-count":129,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,2]]}},"alternative-id":["982"],"URL":"https:\/\/doi.org\/10.1007\/s11357-023-00982-4","relation":{},"ISSN":["2509-2723"],"issn-type":[{"value":"2509-2723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,23]]},"assertion":[{"value":"6 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was waived for this study due to the fact that this work did not involve any human or animal model experimentation, nor clinical trials or direct usage of brain tissues. Instead, the present work is an in silico analysis of digital images previously obtained and compiled by the \u201cAging, Dementia and TBI study\u201d database organizers (Allen Institute for Brain Sciences, University of Washington and the Kaiser Permanente Washington Health Research Institute). Permission for usage in academic research of the downloadable content, including these images, is explicit and encouraged at  (accessed on 17 May, 2023). As it is stated in the Allen Institute legal terms, no further approval is requested for the usage of these data. Informed consent was obtained from all subjects involved in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}